OncoCyte Corp (OCX)
2.75
+0.08
(+3.00%)
USD |
NASDAQ |
Nov 22, 12:10
OncoCyte Total Assets (Quarterly): 70.22M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.22M |
| June 30, 2024 | 74.72M |
| March 31, 2024 | 70.97M |
| December 31, 2023 | 74.89M |
| September 30, 2023 | 81.59M |
| June 30, 2023 | 87.54M |
| March 31, 2023 | 82.80M |
| December 31, 2022 | 100.09M |
| September 30, 2022 | 157.34M |
| June 30, 2022 | 171.05M |
| March 31, 2022 | 146.27M |
| December 31, 2021 | 159.56M |
| September 30, 2021 | 168.34M |
| June 30, 2021 | 177.38M |
| March 31, 2021 | 129.30M |
| December 31, 2020 | 55.42M |
| September 30, 2020 | 57.78M |
| June 30, 2020 | 63.46M |
| March 31, 2020 | 59.50M |
| Date | Value |
|---|---|
| December 31, 2019 | 39.86M |
| September 30, 2019 | 32.77M |
| June 30, 2019 | 37.67M |
| March 31, 2019 | 41.68M |
| December 31, 2018 | 9.518M |
| September 30, 2018 | 12.90M |
| June 30, 2018 | 12.20M |
| March 31, 2018 | 15.58M |
| December 31, 2017 | 10.22M |
| September 30, 2017 | 14.25M |
| June 30, 2017 | 12.14M |
| March 31, 2017 | 15.17M |
| December 31, 2016 | 14.45M |
| September 30, 2016 | 16.86M |
| June 30, 2016 | 7.424M |
| March 31, 2016 | 9.647M |
| December 31, 2015 | 12.73M |
| September 30, 2015 | 14.30M |
| December 31, 2014 | 5.241M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
39.86M
Minimum
Dec 2019
177.38M
Maximum
Jun 2021
101.40M
Average
82.19M
Median
Total Assets (Quarterly) Benchmarks
| Fonar Corp | 212.29M |
| XWELL Inc | 33.78M |
| ProPhase Labs Inc | 91.81M |
| Applied DNA Sciences Inc | 16.69M |
| Veracyte Inc | 1.275B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.50M |
| Shareholders Equity (Quarterly) | 9.711M |
| Current Ratio | 0.5273 |